Tetrabenazine
| CAS号 | 718635-93-9 | 货号 | BCP24156 |
| 中文名 | Tetrabenazine | ||
| 英文名 | Tetrabenazine | ||
| 中文别名 | |||
| 英文别名 | Ro 1-9569; | ||
| 分子式 | C19H27NO3 | 分子量 | 317.42 |
| 生物活性 | The vesicular monoamine transporter type 2 (VMAT2) inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used to treat chorea due to neurodegenerative diseases (such as Huntington chorea) or dyskinesias due to neuroleptic medications (tardive dyskinesia). As of 2019, three VMAT2 inhibitors have become available in the United States for management of dyskinesia syndromes, each with a somewhat different spectrum of approved indications: tetrabenazine (Xenazine and generics: 2008), deutetrabenazine (Austedo: 2017) and valbenazine (Ingressa: 2017). The VMAT2 inihibitors have not been associated with serum enzyme elevations during therapy or linked to instances of clinically apparent liver injury, but they have had limited general clinical use. | ||
| 信号通路 | Ion Channel/Membrane Transporter | ||
| 靶 点 | Monoamine Transporter | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！